Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature

Cardiovasc Revasc Med. 2018 Oct-Nov;19(7 Pt B):874-878. doi: 10.1016/j.carrev.2018.02.011. Epub 2018 Feb 23.

Abstract

Patients in cardiogenic shock due to severe failure of a mitral bioprosthesis have extremely high risk for repeat standard cardiac surgery. This patient population may benefit the most form the least invasive intervention. We report a successful transseptal mitral valve-in-valve implant performed in a patient in cardiogenic shock due to a flail mitral bioprosthesis requiring bridging intravenous inotropic and intra-aortic balloon pump support.

Keywords: Cardiogenic shock; Mitral regurgitation; Mitral valve-in-valve; Transcatheter mitral valve replacement.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Administration, Intravenous
  • Aged, 80 and over
  • Bioprosthesis*
  • Cardiac Catheterization / instrumentation*
  • Cardiac Catheterization / methods
  • Cardiotonic Agents / administration & dosage
  • Echocardiography, Doppler, Color
  • Echocardiography, Transesophageal
  • Female
  • Heart Valve Prosthesis Implantation / adverse effects
  • Heart Valve Prosthesis Implantation / instrumentation*
  • Heart Valve Prosthesis Implantation / methods
  • Heart Valve Prosthesis*
  • Hemodynamics
  • Humans
  • Intra-Aortic Balloon Pumping
  • Mitral Valve / diagnostic imaging
  • Mitral Valve / physiopathology
  • Mitral Valve / surgery*
  • Mitral Valve Insufficiency / diagnostic imaging
  • Mitral Valve Insufficiency / physiopathology
  • Mitral Valve Insufficiency / surgery*
  • Prosthesis Design
  • Prosthesis Failure*
  • Recovery of Function
  • Recurrence
  • Shock, Cardiogenic / diagnosis
  • Shock, Cardiogenic / etiology*
  • Shock, Cardiogenic / physiopathology
  • Shock, Cardiogenic / therapy
  • Treatment Outcome

Substances

  • Cardiotonic Agents